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ABSTRACT
1. ABSTRACT
BACKGROUND:-Leprosy is a disease of public health concern mainly because of its
potential to cause disability in a small proportion of those affected and is a cause for social 
stigma and discrimination. Leprosy, also known as Hansen’s disease is a chronic infectious 
disease caused by mycobacterium leprae, principally affecting the peripheral nerve, mucosa 
of the respiratory tract and the skin of human being.60% of estimated cases of leprosy are 
contributed by India.Multi Drug Therapy (MDT), which is the treatment recommended by 
World Health Organisation (WHO), cures patients and interrupts transmission of leprosy and 
prevent disabilities. However MDT has been associated with problems like undesirable side-
effects, poor compliance, drug resistance and high relapse rates.
AIM:-Present study was undertaken to analyse the prevalence, treatment pattern and drug 
related problems in patients with Hansen’s disease.
METHODS:-A prospective observational study was carried out over a period of six
months among the leprosy patients who receives care from malappuram and Calicut districts. 
Based on the inclusion and exclusion criteria of the protocol reviewed by the ethics 
committee (KIMS ALSHIFA and Calicut medical college) , 104 leprosy were include and 
enrolled for the study.Datas were collected from patient’s medical records , NLEP cards 
(National Leprosy Eradication Programme)which was obtained from leprosy centers & filled 
questionnaires through personal interviews done by the Assistant Leprosy Officer(ALO) of 
the corresponding centers.
RESULTS:-104 patients records were analyzed and obtained the following datas.Higher 
number of leprosy patients belong to the age group of 31-50years. The most prevalent type of 
leprosy was found to be Multibacillary (MB) with 86 cases while paucibacillary (PB) type 
accounted for only 18 cases. Multibacillary type of leprosy was significantly  associated with 
male gender than the female gender.88 (84.61%)Patients showed hypo pigmented patches, 
Loss of sensation were showed by 41 (39.42%) patients followed by numbness 33 (31.73%), 
deformities 19(18.27%). Among 104 patients 62% had ulcer, 33.33% had claw hands 
followed by foot drop 14.28% and lagophthalmus 9.52%. The treatment of multibacillary  
leprosy  was through the use of combination of Dapsone, Rifampicin, and Clofazimine.(74%)
.Paucibacillary leprosy was treated with the combination of Dapsone and Rifampicin(16%). 
Among patients with typr-1 reaction, significantly higher numbers of patients are treated with 
prednisolone, whereas Type-2 reaction was managed by using prednisolone and thalidomide. 
The most prevalent ADR in the patient population was found to be anemia (33%) followed 
by hepatic abnormalities (22%). Majority of the patients was found to be moderately 
adherent. Majority of patients in the sample are continuing the treatment (69%), 21% of 
patients got complete relief from the disease and 11% of patients were found to be defaulters.
CONCLUSION:- Study reveals that most of the patients were in the age group of 31-50 
years and the most prevalent type of leprosy was found to be multibacillary (MB) .74% of the 
Multibacillary patients were treated with MDT-MB regimen with Dapsone, Rifampicin and 
Clofazimine and 16% of the paucibacillary patients were treated with MDT-PB regimen with 
Dapsone and Rifampicin. The most common ADR found by using the MDT regimen was 
anemia and it was managed by using iron supplements
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CHAPTER 1
INTRODUCTION
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1 .INTRODUCTION
Leprosy is a disease of public health concern mainly because of its potential to cause 
disability in a small proportion of those affected and is a cause for social stigma and 
discrimination [1]. The World Health Organization’s (WHO) 2011-2015 global  strategy 
for leprosy control focuses on reducing the rate of new leprosy cases with grade II 
disabilities per 100,000 people by at least 35% at the end of 2015 taking 2010’s occurrence 
as reference. Leprosy, also known as Hansen’s disease (HD) is a chronic infectious disease 
caused by Mycobacterium leprae, principally affecting the peripheral nerve, mucosa of the 
respiratory tract and the skin of human being [2]
HISTORY AND PREVALENCE
Leprosy has affected humanity for over 4,000 years, and was well-recognized in the 
civilizations of ancient China, Egypt, and India [3].Leprosy was referred to as “Kushtha” in 
ancient India. The first authentic description of leprosy and its treatment is given in 
“Sushruta Samhita”, a treatise written in India in 600 BC [4]. Hansen's disease named after a 
physician called Gerhad Armaver Hansen who discovered ‘Mycobacterium leprae in 1873 
[2]. Till the introduction of the drug Dapsone in 1940s there was no treatment for this 
disease; patients were kept in isolation. India contributes to more than 50 % of new cases 
detected globally every year .A total of 1.27 lakh new cases were detected during the year 
2011 -2012.A total of 0.83 lakh cases are on record as on 1st April 2012 given the 
prevalence rate (PR) of 0.68 per 10,000 population.[1]
DETERMINANTS OF LEPROSY
Transmission of Leprosy from source of infection to susceptible host is determined by a 
number of factors related to agent, host and environment. The causative agent, 
Mycobacterium leprae is an obligate intracellular acid fast bacillus (AFB) multiplying 
mainly inside the macrophages of the skin (histiocytes) and of the nerves (Schwann cells). 
Open cases of lepromatous leprosy constitute the principal source of infection. 
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Microorganisms escape from broken nodules and secretion from mouth, nose and pharynx.    
Upper respiratory tract and skin are the two important routes of entry for the bacilli [4]. 
Incubation period for leprosy is variable from few weeks to even 20 years.  The average 
incubation period is said to be 5–7 years [1].
Host factors include age, gender, immunity & socio – economic factors. Leprosy is known 
to occur at all ages ranging from early infancy to very old age [4] .The age at which leprosy 
occurs depends upon opportunities for exposure to infection [5]. Although leprosy affects 
both sexes, in most parts of the world males are affected more frequently than females, 
often in the ratio of 2:1. Higher number of leprosy cases is seen in some hilly, tribal, and 
other isolated communities. Susceptibility to tuberculoid leprosy is probably related to 
HLA types [4]
Leprosy is found more in tropical areas. Large family size and dwellings, especially in 
urban slums, increase the chance of contact and transmission due to overcrowding. Contact 
with leprosy infected persons is slightly to be more among the poor and the ignorant. 
Children of parents suffering from leprosy have higher risk for developing the disease. 
Because of the increased social stigma associated with the disease there is a delay in 
seeking the treatment, thereby increasing the possibility of transmission [5].
PATHOGENESIS OF LEPROSY
Leprosy primarily affects the skin and peripheral nerves. It can also affect the upper 
respiratory tract eyes, liver, testes, kidney, muscles and bones [4]. Bacilli enter the body 
through the respiratory system and migrate towards the neural tissue and enter Schwann 
cells. Bacteria can also be found in macrophages, muscle cells and endothelial cells of 
blood  vessels.  Within  the  cells  bacilli  start  multiplying  slowly  (12-14days  for  one 
bacterium to divide into two), get liberated from the destroyed cells and enter other 
unaffected cells. Until this stage person remains free from signs and symptoms of leprosy. 
Multiplication of bacilli, results in increased bacterial load in the body and the infection is 
recognized by the immunological system. Lymphocytes and macrophages invade the 
infected tissue resulting in the appearance of clinical manifestations as involvement of 
nerves with impairment of sensation and or skin patch. Specific and effective cell mediated 
immunity offers protection to a person against leprosy [1].
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CLASSIFICATION OF LEPROSY
In the National leprosy eradication programme the classification is done according to 
whether leprosy is of multi -bacillary or pauci -bacillary type. [1]
Table:-1 Characteristics of PB and MB form of Leprosy
CLINICAL FEATURES OF LEPROSY
Leprosy symptoms generally appear three to five years after a person becomes infected 
with bacteria that cause the disease. The symptoms include :Hypo- pigmented or  reddish 
skin lesions with decreased sensation to touch, heat, or pain and lesions do not heal after 
several weeks to months; Numbness or absent sensation in the hands, arms, feet, and legs; 
Muscle weakness; Eye problems; Skin rash; Skin stiffness ; Infiltration/thickening of 
skin:- Reddish or skin colored nodules or smooth shiny diffuse thickening of skin without 
loss of sensation ; Involvement of peripheral nerves:- Cord like thickening of nerves with 
or without pain and tenderness: especially behind the ear, around elbow, wrist, knee and 
ankle joints .Disabilities and deformities of hands, feet and eyes [3]
Sl.NO. Characteristics PB(Pauci bacillary) MB(Multi bacillary)
1. Skin lesions 1-5 lesions 6 and above
2. Peripheral nerve involvement No nerve/only one 
nerve with or 
without 1-5 lesions.
More than 1 nerve 
irrespective
o
f number of skin 
lesions
3. Skin smear Negative at all sites Positive at any sites.
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Table 2Characteristics of sub-types of borderline leprosy [4]
DIAGNOSIS
Cardinal Signs of Leprosy include
∑ Hypo - pigmented or erythematous, well-defined skin lesions, e.g. macules or 
plaques, with definite loss of sensation.
∑ Signs of peripheral nerve damage, such as sensory loss, paralysis or pseudomotor 
dysfunction with or without nerve enlargement.
∑ Finding acid-fast bacilli in the skin smears and/or biopsies taken from the skin 
lesions.
Characteristics Borderline-
Tuberculoid (BT)
Mid-
Borderline (BB)
Borderline 
Lepromatous (BL)
Skin lesions: 
Number
Few Some Many
Distribution Asymmetrical Asymmetrical Roughly 
symmetrical
Description Usually well-
demarcated, 
Somewhat dry. 
May be annular 
with
clearly defined 
outer
Border. Surface 
may
Be scaly.
Less well-
demarcated, 
Somewhat shiny 
lesions.
Often annular 
lesions
with characteristic, 
punched-out 
appearance
(the outer border 
is vague, while the 
inner border is 
clearly
Defined).
Shiny macules, 
papules,
nodules and plaques 
with sloping edges
Sensory impairment 
in lesions
Marked Moderate Slight
Peripheral nerve 
involvement
Widespread or 
asymmetrical
Widespread or 
asymmetrical
Widespread and 
less 
Asymmetrical
Pauci- bacillary or Pauci - bacillary Multi - bacillary Multi – bacillary
Reactions Reversal (Type Reversal (Type Reversal and/or 
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At least one of the above three must be present for the diagnosis of leprosy. Other 
investigations that can be used for diagnosis of Leprosy are:-Examination of nerves, 
Bacteriological examination, Biopsy and Histo-pathological examination, sweat  function  
test,
GRADING OF DISABILITIES
Immunological reactions are the main cause of nerve damage, which in turn is the main risk 
factor for long term disability in leprosy [6]. Peripheral nerve involvement is the chief  cause  
of  permanent  disability in  leprosy  .The  problem  of  disabilities assumes increasing 
importance not only in terms of evolving better methods of treatment, correction of 
deformities and rehabilitation of the disabled, but also with regard to better medical 
management of patients under anti - leprosy therapy [7]. The major risk factors known for 
leprosy disability and physical deformity are delay in diagnosis, delay in provision of proper 
care for the disease, multiple nerve enlargements, and the type of leprosy (pauci or multi 
bacillary), smear result and age (6-8) [8]. Patients developing reactions are at a higher risk of 
developing disabilities and deformities compared to people who do not develop reaction [1] 
The EHF score is used to grade the disability of the individual organ separately and to give 
an overall disability grade to the person. The highest grade of disability given in any of the 
part is used as the Disability Grade for  that patient. EHF score i.e. sum of all the individual 
disability grades for two eyes, two hands and two feet (0–12). [4]
DG 0 - no disability caused by leprosy in eyes, hands and feet
DG 1 – Anaesthesia present, over palm / sole but no visible deformitiy or damage...
DG 2 – Visible deformity or damage present [1]
Table 3
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Deformities occurring in leprosy [4]
Face lagophthalmos, loss of eyebrows (superciliary madarosis) and 
eyelashes , corneal ulcers and opacities, perforated nose, depressed 
Hand Claw hand, wrist-drop, ulcers, absorption of digits, thumb-web 
contracture, hollowing of the inter - osseous spaces and swollen hand.Feet Plantar ulcers, foot-drop, inversion of the foot, clawing of the toes, 
absorption of the toes, collapsed foot, swollen foot and callosities
LEPRA REACTIONS
It occurs due to sudden alteration in the immunological status of the host against 
the living or dead bacilli. It can occur at any time either during the course of 
disease, during treatment or even after the completion of treatment with 
MDT .There are two types of lepra reactions:-
1. Type 1 Reactions
2. Type 11 Reactions
Type 1 Reactions:-
It is a delayed hypersensitivity response which is also called as Reversal reactions. It 
presents as inflammation of the existing skin lesions i.e. increase in redness, swelling, 
tenderness/discomfort and rarely ulceration appearance of few new inflamed skin lesion 
and/or neuritis.
Type 2 Reactions:-
It is also called Erythema Nodosm Leprosum (ENL).It usually occurs in MB type of 
leprosy. During the course of treatment a large number of bacilli are killed and its antigen 
is been produced .It combines with the antibodies and form immune  complexes .These 
immune complexes deposit within the tissue and result in inflammation .The organs that 
involved in these type of reaction are eyes ,testis, kidney, liver, nerve, endocardium and 
joints. Neuritis is always accompanied with type2 reactions. [1]
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TREATMENT
The development of multidrug therapy (MDT) changed the face of leprosy  dramatically. 
The treatment consists of combination of three drugs, Rifampicin, Dapsone, and 
Clofazimine. MDT made it possible to cure patients, interrupt the transmission of leprosy, 
and thus – most important for the social perception of the  illness and to prevent 
disabilities. Even patients with the severest form of the disease show visible clinical 
improvement within weeks of starting treatment. In 1981, the World  Health  Organization  
(WHO)  recommended  MDT  as  the  standard treatment against leprosy [4]. MDT 
introduction came with additional benefits such as an intense monitoring of patients, 
coverage of affected populations, and improvement of the closeness between leprosy 
patients  and medical care, and that  leprosy changed into a curable disease  [9]. PB leprosy 
is treated with with dapsone and rifampicin for a period of six months while MB leprosy is 
treated with Dapsone, rifampicine and clofazimine for a period of 12 months [10] .WHO has 
designed blister pack medication kits for both PB and  MB leprosy. Each easy-to use kit 
contains medication for 28 days [11]
Advantages of Multidrug Therapy [1] include
∑ Reduces chances of development of resistance to the drugs. 
∑ Duration of treatment is short and fixed.
∑ MDT is safe, has minimal side effects and has increased patient compliance. 
∑ Available in blister pack; easy to dispense, store and take.
Assessing fitness of a Leprosy patient for MDT
Treatment of leprosy under MDT depends upon the clinical group to which the patient 
belongs [10]
∑ Jaundice: If the patient is jaundiced, wait till jaundice subsides.
∑ Anemia: If the patient is anaemic, treat it simultaneously along with MDT. 
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∑ Tuberculosis: If the patient is taking rifampicin, ensure that he/she continues to 
take rifampicin in the dose required for the treatment of tuberculosis along with 
other drugs regimen required for the treatment of Leprosy.
∑ Allergy to sulpha drugs: If the patient is known to be allergic to sulpha drugs, 
dapsone should be avoided [1].
Table 4
WHO recommended treatment regimens [11]
Type of 
leprosy
Drugs used Frequency
o
f administration 
Adults(children 
in bracket)
Dosage 
(adult)15 
years
an
d above
Dosage 
children 
between 10-14 
years
Dosage 
children 
Below
1
0 year
MB
Leprosy
Rifampicin Once monthly 600mg 450mg 300mg
Clofazimine Monthly 300mg 150mg 100mg
Dapsone Daily once 100mg 50mg 25mg
Clofazimine Daily
for 
adults(every 
other day
for 
50mg 50mg(alternate 
day, not daily)
50mg 
(weekly 
twice)
PB
Leprosy
Rifampicin Once monthly 600mg 450mg 300mg
Dapsone Daily 100mg 50mg 25mg daily 
or
50m
g alternate 
day
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COMMON DRUGS USED FOR THE TREATMENT OF LEPROSY
CLOFAZIMINE:-
It is a dye with leprostatic and anti-inflammatory properties; which is a major advantage of 
clofazimine over other antileprosy drugs and therefore it has a vital role in the management of lepra 
reactions [12, 13]. Clofazimine is used for dapsone resistant leprosy in patients intolerant to dapsone 
[13]. Clofazimine acts by blocking the template function of DNA by binding to its guanine bases and 
there by inhibits bacterial proliferation [5]. Adverse Effects include: discoloration of skin, hair, 
cornea, conjunctiva, tears, sweat, and sputum. Dose related gastrointestinal symptoms include pain, 
nausea, vomiting and diarrhea [11].
DAPSONE:-
Dapsone was introduced as the standard chemotherapy for leprosy in 1950s and it is the 
most widely used sulphone for the long term therapy of both MB and PB types of leprosy [13, 
14]. It is a bacteriostatic agent and acts by inhibiting the De Novo synthesis of folic acid [15]. 
Haemolytic anaemia is the most important toxicity and it is common in patients with G6PD 
deficiency.Others adverse effects include anorexia , nausea,  
methaemoglobinemia ,headache , paresthesias , mental symptoms , hepatitis , 
agranulocytosis , lepra reaction  and sulphone syndrome [12] .
RIFAMPICIN:-
It is an important drug used in MDT regimen because of its ability to shorten the treatment 
duration when given in combination with dapsone. It is a bactericidal agent and acts by 
inhibiting the DNA dependent RNA synthesis. Adverse effects include: - Hepatitis is the 
major dose related adverse effect (liver damage). Other serious but rare   reactions   include   
respiratory   syndrome,   haemolysis,   purpura,   cutaneous syndrome, flu syndrome, 
abdominal syndrome, renal failure [12].
OFLOXACIN
It is usually used if rifampicin is not used in the therapy or those patients who refuse to take 
clofazimine or to shorten the duration of the treatment.99.9% of bacteria are usually killed 
by 22 daily doses of monotherapy of ofloxacin. Inhibits bacterial DNA gyrase and 
ultimately resulting in the bacterial cell death. Usual dose: 400mg/day.
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Adverse effects include:-Aplastic anaemia, Hepatitis, toxic epidermal necrosis, 
Agranulocytosis etc [12]
MINOCYCLINE
Minocycline is a semisynthetis tetracycline. It is used in PB cases in combination with 
rifampicin and ofloxacin. In MB case it is used when patients refuse to take clofazimine or 
those patients who could not take rifampicin. It mainly helps to inhibit the protein synthesis 
thus by producing a bacteriostatic effect. For adults single dose of 100mg was preferred. 
Adverse effects include:-Vestibular disturbances, Dizziness, Vertigo GI irritations, 
Phototoxic reaction, hypersensitivity reaction etc [12].
MANAGEMENT OF LEPRA REACTIONS PREDNISOLONE:-
It is a synthetic glucocorticoid with weak mineralocorticoid properties. It is used for the 
treatment of lepra reactions or neuritis or inflammation in the eyes of the leprosy patients. It 
prevents the inflammation by suppressing the migration of fibroblast and reversing capillary 
permeability and also by controlling the rate of protein synthesis. An adverse effect mainly 
depends upon the dosage and duration of therapy. Common side  effects  include  moon  
face,  acne,  bruising,  muscle  wasting,      amenorrhea, hirsutism etc [4, 11].
ANALGESICS:-
Aspirin (acetyl salicylic acid) is still the cheapest effective drug for controlling the moderate 
degrees of pain and inflammation and it is also commonly used in cases of leprosy 
supportive management. 600mg given 4 times daily with meals .Dosage is reduced as signs 
and symptoms are being controlled. Inhibits the synthesis of prostaglandin by cyclo-
oxygenase; inhibits platelet aggregation and has analgesics activity. Adverse effects include 
vomiting, epigastric distress, increased occult blood. loss in stools, gastric mucosal damage, 
peptic ulceration, angioedema, anaphylactic reaction, vertigo, electrolyte imbalance etc [4].
THALIDOMIDE
It was banned in 1960 for its teratogenic effects. But now days it is used to manage lepra 
reactions. It down modulates the cell surface adhesion molecules involved in leukocyte 
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migration. Its half life is about 5-7 hour .Adverse effects:-photosensitivity, bradycardia, 
neuropathy, vertigo etc. Treatment with thalidomide is only recommended in tertiary care 
hospitals after taking necessary consent. Since this drug is teratogenic, it is contraindicated 
for use in women of reproductive age group [1, 4].The burden of leprosy can be measured in 
terms of the occurrence of reported new cases, or of the number of cases registered for 
treatment, or the number of cases with disabilities [8].  The consequent lack of treatment or 
delayed treatment resulted in an increased risk of disabilities, which in turn strengthened and 
perpetuated the stigma of the disease .The principle of reducing the load of infection in 
society, to break the chain of infection, is the cornerstone of leprosy control work today. It 
implies early diagnosis and early adequate drug treatment to make the patient non-infectious 
[4].
SIGNIFICANCE OF THE STUDY
Current situation in Kerala showed an increase in number of leprosy patients with several 
fresh cases being reported during the past one year. The health department data showed that 
796 fresh cases of leprosy have been reported in the state in 2014 -2015 period. The highest 
number of fresh cases has been reported at thiruvananthapuram – 111, Palakkad - 91, 
Ernakulum – 90 and Thrissur -84. Multi drug therapy (MDT), which is the treatment 
recommended by WHO has been associated with problems like undesirable side effects, 
poor compliance, drug resistance and high relapse rates. Thus the present study was 
undertaken to assess the current prevalence of leprosy in two districts in Kerala 
(Malappurum and Calicut) and to analyze the treatment patterns & drug    related    problems    
like adverse effects associated with the disease
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CHAPTER 2
REVIEW OF
LITERATURES
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2. LITERAT
URE
REVIEW
1. B.L. Ajibade, Okunlade, Olawale Femi, O.P. Adisa, M.O.A Adeyemo (2) Conducted a 
retrospective and cross-sectional carried out to determine the yearly prevalence, most 
prevalent type of leprosy ,perceived psychological impacts and modes of treatment of 
leprosy for a period of 5 years(January 2005 – December 2010)Sample size consisted of 77 
respondents that were selected randomly. Self designed questionnaire was used to assess the 
perceived psychological impacts of leprosy. The study results showed a decline in yearly 
prevalence of leprosy.. The issue of leprosy was pronounced in males than females with the 
pick recorded in the year 2005.Treatment of multibacillary leprosy were through the use of 
combination of rifampicin, dapsone and clofazimine. Paucibacillary was treated with 
combination of rifampicin and dapsone.
2. Harminder singh, bithika nel, Vivek dey, pawan tiwari & Naveen dulhani 
(2008) (17) Conducted a prospective observational study carried out in the department 
of dermatology, Jagdalpur, to assess the adverse effects of multidrug therapy (MDT) 
in leprosy patients.The advers effects were recorded on the personal record of every 
individual patient, filled during the course of treatment.176 patients were included in 
the study, 97(55 %) were  males and 79(45%) were females. 106 (60%) were treated 
with MDT MB and 70(40 %) were given MDT PB. Among the 176 patients, 79 had 
adverse effects due to one or more components of MDT, 73 had adverse effects due 
to dapsone, 8 due to rifampicin and 16  due to clofazimine .Mean duration for the 
development of adverse effects from the start  of therapy was 1.99 +/-0.69 months 
for dapsone, 3.6 +/- 0.68 months for rifampicin and    7.13 +/- 0.79 months for 
clofazimine.
3. Sileshi Baye (2011) (18)Conducted a form of longitudinal ecological study design 
was employed to describe the epidemiological trends and changes of leprosy in 
Ethiopia from 2000 to 2011. Data on variables of interest were collected from health 
and health related indicator reports and database of the FMoH. Health institutions 
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across the country routinely collect the data  using a standardized Health 
Management Information System (HMIS) reporting format. On average, 5,034 
leprosy cases were recorded nationally every year. Out of these, the average number 
of new cases of leprosy was 4,475 (88.9%).Multi-bacillary cases of leprosy were the 
predominant 3,963 (88.7%) form of the disease. Overall childhood leprosy rate and 
grade-2-disability rate respectively were 7.1 and 9.3 per 100 new cases. The 
treatment success rate was more than 86 per 100 registered cases. A yearly average 
relapse rate of 4.8 per 100 total cases (242 on average per year) was recorded while 
a total of 188 leprosy patients (3.7 per 100 total cases) defaulted from follow-up 
between 2000 and 2011.
4. PSS Rao (2008) (19) This study was done in two phases: In the first phase , a 
representative sample of Six leprosy mission hospitals in UP , Delhi, West Bengal , 
Maharashtra were chosen for estimating the defaulter rates and their association with 
selected socio-demographic factors. For the second phase, three of these centers 
were randomly chosen for ascertaining the reasons for defaulting. A total of 6291 
new untreated cases of leprosy who received MDT in the six TLM hospitals were 
followed up. Including the 1st dose, the overall defaulter rate for patients within the 
district was 46%, and for those outside the district, 60%. Patients from outside the 
district had significantly higher defaulter rates for both MB and PB (p<0.05). Of 
those who were contacted , the reasons for defaulting was found to be psychosocial 
in 176 patients (43.3 %) , health related in 102 patients(25.2 %) & medical reasons 
in 54 patients. Generally, the women patients defaulted more due to medical 
problems.
5. Huan-Ying Li, Lu-Fang Hu, Pei-Wei Wu, Jiu-Si Luo, and Xue-Ming Liu2 (1992) (20)  A 
prospective cohort study conducted to study the relapse rates after fixed duration-MDT, the 
critical bacterial index (BI) before MDT which is necessary to prevent relapse.657 active 
MB leprosy patients were put on fixed duration –MDT between 1985 & 1992 and were 
followed for 5 years after therapy. The study results showed that male/female ratio is 4:1 
(323/79) for MB patients without & 6:1(218/37) for MB with previous dapsone  therapy. 
Reactions occurred more frequently during the first 6 months (12%), decreasing gradually 
from months 7to 24 of MDT. Significantly more reactions occurred in the 20-39 age group 
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than in the 40-59 age groups in the present study. Reactions were treated with prednisone 
(30-60 mg/day), gradually tapering off within 6 months. Some ENL reactions received 
thalidomide 200-300mg/day in addition to prednisone. Eleven patients developed 
hypersensitivity reactions to dapsone. Three patients developed liver damage with  abnormal 
liver function tests after 3-20 months' administration of MDT. They received palliative 
therapy for liver damage and MDT was continued after a temporarybreak.
6. Shivlal Rawlani*, Adarsh lata Singh**, Rahul Bhowte*, Shirish Degwekar*et-
al (2012) (21)Cross-sectional study to assess cutaneous and mucocutaneous lesions 
in leprosy patients taking multidrug Therapy .The study population comprised of 
30 admitted leprosy patients for taking multidrug treatment .The study was 
conducted over a period of 7 days. The recorded data were tabulated and analyzed 
using chi square test and student t- test. Patches were the most common type of 
cutaneous lesions (90%) observed in leprosy patients taking multi drug therapy, 
followed by ichthyosis/dryness of skin (60%), atrophy (26.75%), and hair loss 
(20%) while only 13.4% patients showed papules and infiltrated lesions. There  
was multiple nerve involvement in patients taking multi drug therapy; out of that 
ulnar nerve is most commonly affected followed by radial nerve and post auricular 
nerve. Deformities found in these patients were in the form of claw hand (16.7%), 
lagophthalmos (13.4%), ulcer (6.7%) and absorption (3.3%).
7. Patricia d. deps *, Sofia Nasser *, Patricia guerra *, Marisa Simon*et-al (2007) 
(9) Conducted a retrospective, descriptive study in Brazil to assess the, adverse 
effects from Multi-drug therapy in leprosy. 194 patients were included in this study, 
78 (40%) male and 116 (60%) female. 40% were MB and 60% were PB; 34% of the 
patients were under 30 years old, 51% 31-60 year old and 15% over 60 year old. 
Side-effects were attributed to at least one MDT component in 88 (45%) patients; 85 
had side-effects due to dapsone, 24 due to rifampicin and 18 due to clofazimine. 
Eighty-five patients had adverse effects from dapsone such as hemolytic anemia, 
gastrointestinal manifestations, hepatic abnormalities, dizziness, headache, and 
leucopenia. The present study shows side-effects in 88 (45%)patients and an 
alternative treatment regimen was needed in 47 out of 88 (24%).Alternative 
regimens should be administered under direct supervision : Daily administration of 
50mg  of clofazimine, together with 400 mg of ofloxacin and 100 mg of 
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minocycline for 6  months; followed by daily administration of 50 mg of 
clofazimine, together with 100 mg of minocycline or 400 mg of ofloxacin for at 
least an additional 18 months could be used to replace rifampicin in adult MB
patients.
8. S. Karat, P. S. S. Rao and A. B. A. Karat (1971) (7) Conducted an 
epidemiological study to assess the Prevalence of Deformities and Disabilities and 
nerve involvement Among Leprosy Patients in an Endemic Area (Gudiyatham 
Taluk,, South India. The prevalence of leprosy was 29 per 1,000 populations. Of 
1,780 patients, 1,721 or 97% could be assessed, these consisted of 716 men, 498
women and 507 children (under 15 years of age) .343 were lepromatous, 1,052 
tuberculoid, 155 borderline, 168 indeterminate and 3 were purely neural cases. The 
nerves considered were the ulnar, median, radial, lateral popliteal, and facial. 
Lepromatous and borderline cases were the most affected (nearly two-thirds) as 
compared to only 23% among tuberculoid and 18% among indeterminate. The 
differences were highly significant (P < .01) the motor nerve most affected was the 
ulnar nerve and the least was the radial nerve. There was a significantly higher 
percentage of disability among patients with bacillated types.
9. Tigist S. et al (2010) (8) Conducted A cross sectional retrospective study to 
determine the Prevalence of Disability and Associated Factors among Registered 
Leprosy Patients in All African Tb and   Leprosy delay. One hundred and twenty 
one participants, (99.2%), reported presenting to a medical doctor within 5 years of 
symptom onset and no patient delay exceeded 10 years Rehabilitation and Training 
Centre Medical records of leprosy patients registered from September 11, 2010 to 
September 10, were reviewed. The calculated sample size was 513. Out of those 
involved in this study, 98.1% reported by themselves; of these, 328(63.9%) were 
male and 185(36.1%) were females patients. 25 (4.9%) of the leprosy patients were 
aged less than or equal to 14 years. 225 (43.9%) were aged 15 to 30 years. 172 
(33.5%) were in the age group of 30-50. The remaining 91 (17.7%) were above 50 
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years old. 379(73.9%) of the patients were newly diagnosed cases of leprosy, 
11(2.1%) were returnees after default, 35(6.8%) were relapse and the remaining 
88(17.2%) were in other categories. Almost all of the patients were multi-bacillary 
(MB) leprosy cases, 509/513(99.2%). Among those with disability, 40.2% had grade 
I and 25.7% had grade II disabilities. Age, duration of symptoms, sensory loss and 
nerve damage and reversal reaction are the factors found to be associated with
disability.
10. Henry et al (2014) (22) Conducted explorative, Quantitative, Questionnaire Based 
Study 56 participants were recruited from ILSL: 43 outpatients, 7 inpatients and 6 
residents. This exploratory study used a self-constructed, quantitative questionnaire 
which was delivered to participants over a seven-week recruitment period in 
February/March 2014. In the questionnaire, participants were asked to report the 
time elapsed between first noting leprosy symptoms and visiting a medical doctor 
for these symptoms. This was labeled as patient delay. Participants were also asked 
to report the time that elapsed between their first visit to a medical doctor and them 
receiving a diagnosis of leprosy/Hansen’s disease. This was labeled as health  
system delay. One hundred and twenty one participants, (99.2%), reported 
presenting to a medical doctor within 5 years of symptom onset and no patient delay 
exceeded 10 years.
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11. Nitin.J.Nadkarni*Antonio Grugni*and Manjunath S Kini (1992) (24) Conducted 
a fixed duration of MDT in paucibacillary patients. They analyzed the records  of 
1022 patients of PB leprosy who had received 6 doses of WHO-MDT alone or had 
post- dapsone for 6 months Monthly clinical assessments, random tablet counting, as 
well as urine tile testing for dapsone are done routinely to ensure compliance. The 
duration of post therapy surveillance ranged from 6 months to 7 years. They found 
that the incidence of unfavorable events was significantly higher with the classical 
regimen when patients were graded as active at the end of the fixed duration
regimen, especially when patients with >2lesions were considered.6 doses of MDT 
is adequate in the majority of patients who have few lesion or who have become 
inactive at the end of the treatment.
12. Luzivander S Soares*Rodrigo De O* Vanesa V. Vilela*et-al (2000) (25) they
investigated the impact of MDT on the epidemiological pattern of leprosy in juiz de 
for a, Brazil, from 1978 to 1995.Evaluation of 1283 medical charts was performed 
according to the treatment regimen used in two different periods. They were 
analyzed to determine annual incidence and prevalence of the disease. The results 
show that multibacillary forms of leprosy predominate over the paucibacillary in 
both study periods. The number of new cases recorded in juiz de for an exceeded the 
number of discharge of patients on active file from city health units, such that the 
total number of registered cases increased every year. They also found that there is 
increased incidence of leprosy  at extreme ages
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CHAPTER 3
AIM AND OBJECTIVES
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3. AIMS AND OBJECTIVES
3.1 AIM
Study the treatment pattern of leprosy in two districts in Kerala
3.2 OBJECTIVE
1. To study the prevalence of the disease.
2. Monitor presence of adverse drugreaction,
3. To study the treatment pattern of leprosy including lepra reactions
4. Assess adherence to drug therapy
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CHAPTER 4
METHODOLOGY
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4 .METHODOLOGY
STUDY SETTING
Participants for this study were selected from various regions of Malappuram and Calicut 
districts. In Calicut district, the study was carried out in the dermatology department of 
Calicut Medical College located in the city of Kozhikode that has grown into the premier 
centre of medical education in Kerala. The medical college campus houses several 
institutions like government dental college, government nursing college, college of 
pharmacy, institute of maternal and child health, super -specialty blocks and institute of 
chest diseases. The various specially includes general medicine , radiotherapy , surgical 
gastroenterology , dermatology & venerology ,ENT , orthopedics, preventive clinics , 
psychiatry , plastic surgery , ophthalmology , general surgery etc . Hospital is equipped  
with MRI, CT scan, 2D echo & Doppler study, angiography, thoracoscopy , pathology and 
microbiology lab etc.
In Malappuram district data was collected perinthalmanna district hospital, ponnani taluk 
hospital. Perinthalmanna district hospital is located in the perinthalmanna taluk of 
malappuram district with various departments such as ENT, Ortho, ophthalmology ,dental, 
pediatrics etc .Ponnani taluk hospital also has various efficient doctors with various 
departments and it is been located in the rural area of ponnani.
STUDY PERIOD
A prospective observational study was carried out over a period of six months among the 
leprosy patients who receives care from malappuram and Calicut districts.
STUDY DESIGN
An observational cross – sectional study was conducted in the leprosy centers in 
Malappuram & Calicut districts. Cross- sectional studies can be thought of as providing a 
snap shot of the frequency of health related characteristics in a population at a single point 
of time.
SOURCE OF DATA
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Sources of data include patient’s medical records; NLEP cards (National Leprosy 
Eradication Programme) obtained from leprosy centers & filled questionnaires through 
personal interviews
FORMS USED IN THE STUDY
A well designed patient data collection form and medication adherence questionnaire were 
developed by the team members with the help of guide for recording the patient case 
details.
DATA COLLECTION FORM
A data collection form was designed after assessing different standard forms that mainly 
covers aspects like,
∑ Patient demographic details - which includes the basic information of patient 
along with sex, age, date of admission
∑ Social History
∑ Reason for consultation – which includes the clinical features
∑ Past medical & medication history – Co -morbidities of patient along with the 
drugs the patient was taking for long back was documented here.
∑ Diagnosis - it includes provisional conclusion of patient regarding the signs & 
symptoms and skin biopsy reports.
∑ Assessment of disability and nerve function
∑ Treatment pattern- detailed information regarding the medication including the 
dose, frequency, route of administration was recorded.
∑ Adverse drug reactions – adverse reactions experienced by the patient while 
taking multi-drug therapy
∑ Relevant lab parameters
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MEDICATION ADHERANCE QUESTIONNAIRE
A well designed medication adherence questionnaire was developed to assess patient’s 
adherence to drug therapy. Medication adherence- the questionnaire consists of 12 questions 
evaluating the medication adherence of patients with two options to answer i.e.; yes or no 
.the positive results were given a score of +1 and negative results a score of -1 .the 
medication adherence is graded into three categories; highly adherent (>6) moderately 
adherent (0-6)and non-adherent (<6).
PATIENT SELECTION
Based on the inclusion and exclusion criteria of the protocol reviewed by the ethics 
committee (KIMS ALSHIFA and Calicut medical college), 104 leprosy were include and 
enrolled for the study
Inclusion Criteria:
∑ All patients diagnosed with leprosy (old and new cases)
∑ No age limit
∑ Both genders are included
Exclusion Criteria:
∑ Immigrant patients
∑ Patients in whom the relevant data not available
STUDY PROCEDURE
This observational cross sectional was conducted at Malappuam & Calicut districts over a 
period of six months. Study title was selected based on our area of interest and under the 
guidance of our project guide. We reviewed around 15 literatures related to the topic and 
prepared study protocol. A well designed patient data collection form and medication 
adherence questionnaire were developed after assessing different standard forms by the 
team members with the help of guide for recording the patient case details .The protocol 
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along with the study materials were submitted to institutional ethics committee for 
approval and ethical clearance were obtained from our hospital and Calicut medical 
college prior to initiation of the study. Data collection was done prospectively from the 
secondary data available from the leprosy centers in Malappuram & Calicut districts and 
through personal interviews. Full details of the case including patient demographics, past 
medical and medication history, clinical features, lab investigation details, treatment 
pattern, adverse drug  reactions and  other  details  were  brought  into  self  designed  data  
collection  form Disability grade of the patient was assessed with the help of EHF ( eye , 
hand , feet ) score. Patients were categorized into grade 0, grade 1 and grade 2 disabilities. 
Medication adherence questionnaire was used to evaluate patient’s adherence to multidrug 
therapy. The data was entered in Microsoft excel for easy reference and analysis of results 
later. The entire data collected were analyzed using different statistical method in 
consultation with the statistician. The sample size for the study was set as 104. Z test was 
used for comparison of proportion and Chi square test for testing the goodness of fitness of
ratio.
STATISTICS
The sample size for the study was set as 104 by taking the P value as 88.7 % with a 
confidence of 95% and an error of estimate of 6.1 %. Simple random sampling technique 
was adopted for drawing patients to the study. Chi square test for testing the goodness of 
fitness of ratio
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CHAPTER 5
RESULTS
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5) RESULTS
AGE WISE DISTRIBUTION OF RESPONDENTS
A total of 104 patients were included in the study. Significantly higher number of patients 
belongs to the age group 31-50years (χ2  =36.385, DF=3, p<0.001). Mean ± SD of 
age=42.13 ± 18.61 years, followed by 16-30 and 51-99 years. Least common age group 
was found to be 0-15.
Fig. 1
GENDER WISE DISTRIBUTION OF RESPONDENTS
The gender wise distribution showed that the issue of leprosy was pronounced in males  
than females (χ2 = 18.615, do = 1, p<0.001).
Fig. 2
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RESIDENTIAL STATUS OF RESPONDENTS:-
The residential status of the responders show that no significant difference could be 
detected between the number of patients from rural and urban sector (χ2 = 0.962, DF = 1, 
p>0.05)
Fig.3
EDUCATIONAL STATUS OF RESPONDENTS
Educational status of the responders were classifies as illiterate, primary secondary and 
tertiary. Significantly higher number of patients had secondary education (χ2 = 25.730,   
DF
= 3, p<0.001)
Fig. 4
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TYPE OF LEPROSY
The most prevalent type of leprosy was found to be Multibacillary (MB) [χ2 = 22.231, DF 
= 1, p<0.001] with 86 cases while paucibacillary (PB) type accounted for only 18 cases. 
This indicates  that  most of  the  respondents  suffered  from  multibacillary  types  of   
leprosy.
Fig. 5
CLINICAL FORM OF LEPROSY
Clinical form of leprosy were Borderline borderline, Borderline tuberculoid, borderline 
lepromatous, Lepromatous leprosy...Among these Borderline tuberculoid(BT) form of 
leprosy (69 cases) was found to be significantly higher in the sample (χ2 = 127.391 , df = 
3, p < 0.001) followed by lepromatous leprosy with 16 cases.
Fig. 6
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CLINICAL FEATURES OF LEPROSY
88 (84.61%)Patients showed  hypopigmented patches, Loss of sensation were showed by  41 
(39.42%) patients followed by numbness 33 (31.73%), deformities 19(18.27%),slippage of 
chappals 18(17.30%) ,icthyosis 11(10.58%), madarosis 7(6.73%) and epistaxis 4(3.84%) are 
shown in the above figure.{ χ2 = 191.300 , df = 7 ,p<0.001}
Fig. 7
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DURATION OF SIGNS AND SYMPTOMS
Duration of Signs and symptoms were found to be significantly higher in patients with 
1-10 years duration compared to the other two groups (χ2 = 41.857 , df = 2 , p<0.001)
Fig. 8
TYPES OF LEPROSY PATIENTS
The patients came for the treatment were categorized as new cases(Newly 
reported),Retreat and Relapse .Among these New cases (84%) was found to be 
significantly higher than retreatment (6%) and relapse cases(10%) is shown in the 
above graph.[ χ2 = 122.143 , df =  2 , p  < 0.001]
Fig. 9
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TYPE OF LEPROSY VERSUS GENDER
Multibacillary type of leprosy was significantly associated with male gender than  the 
female gender (χ2 = 21.511, DF = 1, p<0.001)
Fig. 10
NERVE INVOLVEMENT IN LEPROSY
Among  104  patients , 46% showed  ulnar  nerve  involvement  ,  26% showed
common peroneal nerve involvement , followed by radiocutaneous nerve 15% , radial nerve 
5% . (χ2= 57.423, p <0.001)
Fig. 11
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LEPRA REACTIONS
Type 1 reaction was found to be significantly higher than type2 reaction (χ2 = 
7.258, DF = 1, P <0.01)
Fig. 12
TYPE OF DISABILITY
Types of disability were evaluated among 104 patients. 62% had ulcer, 33.33% had 
claw hands followed by foot drop 14.28% and lagophthalmus 9.52% (χ2 = 11.96, DF 
=3, p<0.01)
Fig. 13
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GRADE OF DISABILITY
Grade of disability was evaluated among the leprosy patients.49% had no deformity, 31% 
were having Grade-1 deformity and 20% were having Grade -2 deformity. Number of 
patients in Grade-0 was found to be significantly higher than in Grade-1 and 2.
Fig: 14
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DURATION OF SIGNS AND SYMPTOMS VERSUS DISABILITY 
GRADE
Less than 1year-Grade-1 disability was found to be significantly higher than grade-2 
(χ2 = 4.263, DF = 1, p< 0.05)
1-10 years:-No significant difference between Grade-1 and grade-2 (χ2 = 2.133,
p>0.05)
Greater than 10 years-Patients with grade2 disability was found to be 
significantly higher than Grade1 (χ2 = 4.000, DF = 1, p<0.05)
Fig. 15
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TREATMENT PATTERN OF LEPROSY
Treatment regimens used for managing the patient condition was determined .The treatment 
of multibacillary leprosy was through the use of combination of Dapsone ,Rifampicin,and 
Clofazimine.(74%).Paucibacillary leprosy was treated with the combination of Dapsone  and 
Rifampicin (16%),( χ2 = 209.404 , df =4 , p<0.001)
Fig. 16
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MANAGEMENT OF LEPRA REACTIONS
Among patients with typr-1 reaction, significantly higher number of patients are treated with 
prednisolone compared to others (χ2 = 22.201, DF = 2, p<0.001).Type-2 reaction was 
managed by using prednisolone and thalidomide (χ2 = 10.506, DF =2, p<0.01)
Fig. 17
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ADVERSE DRUG REACTIONS
The most common ADR that was commonly seen at the time of study duration were 
anaemia, GI problems, hepatic abnormality, Flu-like illness, dapsone syndrome, pedal 
odeama etc.The most prevalent ADR in the patient population was found to be 
anaemia(33%) followed by hepatic abnormalities(22%).{ χ2 = 29.692 , df = 6 ,p<0.01}
Fig. 18
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SUPPORTIVE THERAPY
Iron supplements were given for the management of anemia in 26% of patients. 
Antibiotics were being prescribed for 24% of patients in case of exacerbations.
Fig. 19
MEDICATION ADHERENCE
The subjects were categorized into 3 categories namely highly adherent, moderately 
adherent, and non-adherent based on their level of medication adherence .Majority of 
the patients was found to be moderately adherent.( χ2 = 14.657 , df = 2 ,p<0.01 ).18% of 
patients were non-adherent.
Fig.20
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TREATMENT OUTCOME
Among the 104 patients, significantly higher number of patients in the sample are 
continuing the treatment(69%).21% of patients got complete relief from the disease and 
11% of patients were found to be defaulters(χ2 = 14.657 , df = 2 , p<0.01)
Fig. 21
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CHAPTER 6
DISCUSSION
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6. DISCUSSION
A prospective observational study was carried out for six months among the leprosy patients 
in two districts in Kerala (Malappuram and Calicut).The study was carried out to determine 
the prevalence, treatment pattern and drug related problems among the leprosy patients. 
During our study period 40 cases were reported from Malappuram district and 64 from 
Calicut. So the prevalence of leprosy in Malappuram and Calicut district was found to be 
0.001 and 0.002 respectively.
In the current study among among a total of 104 patients included, 49 (47%) were in the age 
group of 31-50 years. The mean age was 42.13±18.61 years. Nearly 6% of the patients were 
aged less than 15 showing the transmission is still going on the community. This high 
prevalence in younger age group calls for more vigorous means of case detection like active 
search for cases especially in communities known to be leprosy endemic.
104 patients were enrolled in the study, of them 74(71%) were males and 30(29%) were 
females, demonstrating male predominance over female population. This result is similar to 
study conducted by B.L Ajibade et-al (2) in which 79.7% was males.
No significant association could be found out between the residential status of patient and 
disease. Leprosy, an ancient disease, was thought to be confined to rural and underdeveloped 
geographical areas. But, on the contrary, our study found no such association, as we found 
an equal prevalence or incidence of the disease in urban and rural regions.
According to our study, the most prevalent type of leprosy was found to be multibacillary 
(MB) with 86 cases (83%) while paucibacillary (PB) type accounted for only 18(17%) cases. 
Similar results were shown in studies conducted by B.L Ajibade et-al(2) and Sileshi 
Baye(18) .The definition of PB leprosy has been evolving over the last two decades, with an 
increasing number of erstwhile PB patients being included in the MB group for the 
treatment purpose. This might be one of the important reasons for the progressive shrinking 
of the pool of PB cases in our study (21).Male gender (63%) showed significant   association 
THE TREATMENT PATTERN OF LEPROSY
PADMAVATHI COLLEGE OF PHARMACY Page 44
with multibacillary leprosy. Considering clinical form of leprosy Borderline tuberculoid 
(BT) form (75%) was found to be predominant over other forms. These results showed 
similarity with the study conducted by S.Karat et-al (7).
Hypo pigmented patches were the most common type of cutaneous lesions (84.61%) 
observed in leprosy patients taking multidrug therapy, followed by loss of sensation over the 
patches(39.42%) and numbness(31.73%). Madarosis were seen in 6.73% of patients. A 
nerve involvement affects sensory nerves earliest and most commonly, but it also affects the
motor and autonomic function of peripheral nerves. In the present study the most commonly 
affected nerves are Ulnar (46%) followed by common peroneal nerve(26%) , radiocutaneous  
nerve (15%) and tibial  nerve (8%).This  findings  was  similar to  the study conducted by 
Shivlal Rawlani et-al.(21)
Delay in diagnosis of patients augments the transmission of infection, and allows 
progression of disease and more severe disability (22).Among the study group 56% of 
patients had duration of signs and symptoms of leprosy within the range of 1-10 years. 
Delay in diagnosis greater than 10 years (5%) have been reported. Leprosy related disability
is preventable if diagnosed early; but many cases are diagnosed late with significant physical 
impairment (8).This study reveals that 51% of the leprosy patients studied had disability of 
grade-1 or grade-2. Among those with disability, 30.77% had Grade-1 and 20.19% had 
Grade-2 disabilities. Among grade-2 disability patients, ulcer (62%) was found to be more 
prominent followed by claw hands (33.33%), foot drop (14.28%). Lagophthalmous were 
reported in 9.52% of patients. On the other hand as per  the  study conducted  by Shivlal  
Rawlani  et  –al(21),  disability in  the  form  of claw  hands (16.7%) was found to be more 
prominent .The major risk factors known for leprosy disability and physical deformity are 
delay in diagnosis, misdiagnosis and delay in  provision of proper care for the disease (8).In 
the present study we were able to establish a significant association between duration of 
signs and symptoms and grade of disability.Grase-2 disability was found to be significantly 
higher in patients who had delay in  diagnosis  of leprosy (>10  years).The longer the 
duration  of symptoms  the higher  the likelihood of developing nerve damage and sensory 
loss,both of which subsequently lead to disability. I f patient had chance of being diagnosed 
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early, they could have been cured from the disease before any of the complications appeared 
(8)
Among 104 leprosy patients, 31 patients developed lepra reactions. Out of this type1 
reaction was found to be significantly higher than type2 reactions.
The treatment pattern of leprosy where analysed in the present study. The treatment of 
leprosy is in the form of multi drug therapy (MDT) which is the combination of 2 or 3 of the 
following drugs. Cap.Rifampicin, Cap.Dapsone, Cap.clofazimine. Out of total 104 patients 
74 cases were treated with combination of Dapsone, Rifampicin and clofazimine. (MDT-
MB Regimen); Patients were treated with combination of Dapsone and Rifampicin (MDT-
PB Regimen). Rifampicin is the most important antileprosy drug and is included in regimens 
for both paucibacillary (PB) and multibacillary (MB) patients. Treatment of leprosy with 
only one antileprosy drug may result in development of resistance to that drug. Treatment 
with Dapsone or any other antileprosy drug as monotherapy should be considered 
unethically. In addition, it would be considerably more hazardous to use the compounds 
separately. These might be the reasons why the combinations were  prescribed (9).
In our study few patients (4 %) were not willing to take clofazimine because of cosmetic
concern. Clofazimine can cause hypo pigmentation of skin and face. In these patients 
clofazimine was replaced with ofloxacin. 2 patients were found to be allergic to rifampicin, 
so the drug was stopped and an alternative regimen was started which is a combination of 
clofazimine, ofloxacin and minocycline. Other antibiotics (24 %) such as ciprofloxacin, 
azithromycin, metronidazole, amoxicillin – cloxacillin combinations were prescribed in 
exacerbative cases. A few patients developed fungal infections like onychomycosis, lichened 
lesions etc and were managed using antifungal drugs (clotrimazole, miconazole, fluconazole 
etc)
Lepra reactions were managed in our study by using analgesics, corticosteroids and 
thalidomide. In type-1 lepra reactions, mild reactions with no evidence of neuritis was 
managed with analgesics such as paracetamol and diclofenac.Type-1 Reactions with nerve 
involvement where treated with combinations of analgesics and corticosteroids such as oral 
prednisolone.The dose is then gradually reduced weakly and eventually stopped.Type-2 
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lepra reactions (Erythema nodosum leprosum) were treated with analgesics and 
corticosteroids; or thalidomide.
According to WHO the frequency of adverse reactions caused by MDT is very low, and 
when such reactions occur, the standard regimen should simply be adjusted, so that 
treatment can be continued. During the study period a total of 73 adverse drug reactions 
Were identified. The most common adverse drug reaction was anaemia (33%) followed by 
hepatic abnormalities (22%), pedal oedema (11%).Dapsone Syndrome was reported in 5% 
of patients. On contrary, the study conducted by Harminder Singh et al [17] revealed that flu like 
illness was found to be more prominent over other adverse drug reactions. Haemolytic 
anaemia was defined as reduction of haemoglobin from base line to the end of 30 – 90 days 
(< 12 .7 g/L for men and <11.5 g/L for women).Iron and folate supplements were given to 
patient (26 %) who had baseline low hemoglobin. Hepatic abnormalities were defined as any 
alterations at liver function tests with or without clinical evidence of jaundice, malaise and 
other symptoms. Liver protectants (9 %) such as silymarin 75 mg and UDCA 150 mg were 
given to patients who had altered LFTs. Flu-like illness include fever, runny nose, sore
throat, cough, muscle/joint aches, and malaise. Gastrointestinal manifestations were 
managed using H2 receptor antagonists (ranitidine) or proton
pump inhibitors (pantoprazole, omeprazole). Management of hypersensitivity 
reactions were done through the use of anti- histaminics (cetrizine and chlorpheniramine 
maleate) in 18 % of patients. Adhering to a treatment schedule and successfully completing 
it are crucial to the control of any disease. In our study majority of patients (49 %) were 
found to be moderately adherent to multi –drug therapy.33 % of patients showed high 
adherence. Non – adherence were reported in 18 % of patients. Significantly higher numbers 
of patients in the sample are continuing the treatment (69%).21% of patients successfully 
completed the treatment and 11% of patients were found to be defaulter. On the other hand, 
the study conducted by PSS
Rao [19] revealed significantly higher number of defaulters. The reasons for defaulting or 
non-adherence may be
Personal factors- stigma and other social, psychological reasons and economic 
reasons such as travel costs, loss of wages, etc
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Medical problems such as worsening of the disease, non - disappearance of patch or 
other symptoms, or even a feeling that they have been cured as their symptoms
disappeared
Health service related factors. - includes complaints about health staff behavior, lack 
of proper instructions or guidance, drug shortage, etc.
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6. CONCLUSION
Leprosy is a chronic disease caused by bacteria Mycobacterium leprae that causes damage to 
skin and peripheral nervous system. The disease develops slowly and results in skin lesion 
and deformities, most often affecting the cooler places on the body.
A prospective observational study was carried for a period for 6 months among the leprosy 
patients in two districts in Kerala .The total number of cases collected for the study purpose 
was 104 and the findings of the study reveals that most of the patients were in  the age  group 
of 31-50 years and the male patients were predominant over the female population. The most 
prevalent type of leprosy was found to be multi - bacillary (MB) and among these MB cases, 
borderline tuberculoid was most commonly reported. Hypo pigmented patches were the most 
common type of cutaneous lesions observed in leprosy patients taking multidrug therapy. The 
finding of the study also illustrates that delay in diagnosis of patients augments the 
transmission of infection, and allows progression of disease and more severe disability.74% 
of the Multi - bacillary patients were treated with MDT-MB regimen with Dapsone, 
Rifampicin and Clofazimine and 16% of the paucibacillary patients were treated with MDT-
PB regimen with Dapsone and Rifampicin. The most common ADR found by using the MDT 
regimen was anemia and it was managed by using iron supplements. Adverse effects 
attributed to MDT are comparable to previous studies and we found that ADR due to Dapsone 
was very high. If patients are properly informed about the common ADR and are advised to 
report to their health care provider if and when ADRs occur, and are appropriately motivated 
about the benefits of MDT, most can be managed by MDT only with supportive treatment, 
without replacing the suspected drug, except in few cases with serious, complicated or life 
threatening ADR. The continuing occurrence of new cases means that the first priority is the 
need for these cases to be detected early and treated effectively to cure leprosy and prevent 
disability. If we fail to do this then the prevalence of leprosy will start to increase and all that 
has been achieved will be lost.
MDT introduction came with additional benefits such as an intense monitoring of patients, 
coverage of affected populations, and improvement of the closeness between leprosy patients 
and medical care, and that leprosy changed into a curable disease. There   are   three   
important   principles   for   leprosy   work   in   the   future.   It includes ;Sustainability (new 
cases of leprosy are continuing and many of the consequences are lifelong so our approaches 
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need to be sustainable) , the leprosy workers cannot do everything themselves(they need to 
work in alliances at all levels with other agencies, other health care workers, social services, 
communities, patients themselves and their families),Anti-leprosy services need to be 
integrated with general health and social services(this includes training, primary health care, 
hospital care, and community based rehabilitation) 
Finally we would like to emphasize the importance of a proper health education, daily ulcer 
care and shoe adjustments as systemic therapy and also to prevent the development of new 
ulcers.
LIMITATIONS OF STUDY:-
The study was a cross-sectional study and thus the follow-up of patients was not 
possible.
Due to fear of stigma and discrimination some patients were not willing to 
cooperate with the study.
Immigrant patients were been excluded because of the difficulty in obtaining the 
relevant information.
The questionnaires were filled with the help of Assistant Leprosy Officers of the 
respective hospitals, because patients visited the leprosy centre one time per 
month. So it was difficult for us to fill up the questionnaires
There is a chance of reporting bias.
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